The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes
Open accessAbstract
Metastatic colorectal carcinoma (mCRC) is a heterogeneous disease with differing outcomes and clinical responses and poor prognosis. CRCs can be characterised by their primary tumour location within the colon. The left-sided colon, derived from the hindgut, includes the distal third of the transverse colon, splenic flexure, descending colon, sigmoid colon and rectum. The right-sided colon, derived from the midgut, includes the proximal two-thirds of the transverse colon, ascending colon and caecum. Sometimes, the rectum is described separately, despite originating from the hindgut, and in many clinical series, the left-sided colon includes only tumours within and distal to the splenic flexure. Differences in the microbiome, clinical characteristics and chromosomal and molecular characteristics have been reported between the right and left side of the colon, regardless of how this is defined. There is now strong evidence from clinical studies in patients with mCRC for the prognostic effect of primary tumour location. The impact of primary colonic tumour location on response to treatment is now under investigation in a large number of clinical studies in patients with mCRC. In this review, we summarise the microbiome, clinical, chromosomal and molecular differences associated with the primary location of CRC. We present an overview of the proven prognostic impact of primary tumour location for patients with mCRC and discuss emerging data for the predictive impact of primary tumour location on clinical outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J. W. W., Comber, H., Forman, D., & Bray, F. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.12.027 · Cited by 5,263
The consensus molecular subtypes of colorectal cancer
Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170
Self-citationESMO consensus guidelines for the management of patients with metastatic colorectal cancer
Van Cutsem, E., Cervantes, A., Adam, R., Sobrero, A., Van Krieken, J. H., Aderka, D., Aranda Aguilar, E., Bardelli, A., Benson, A., Bodoky, G., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw235 · Cited by 3,421
Self-citationScialli, A. R. (1991) · Reproductive Toxicology · doi:10.1016/0890-6238(91)90102-l · Cited by 1,722
Sadler, T. W. (1969) · Medical Entomology and Zoology · Cited by 1,237
Human Gut Microbiome and Risk for Colorectal Cancer
Ahn, J., Sinha, R., Pei, Z., Dominianni, C., Wu, J., Shi, J., Goedert, J. J., Hayes, R. B., & Yang, L. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt300 · Cited by 947
Tumour-associated and non-tumour-associated microbiota in colorectal cancer
Flemer, B., Lynch, D. B., Brown, J. M. R., Jeffery, I. B., Ryan, F. J., Claesson, M. J., O'Riordain, M., Shanahan, F., & O'Toole, P. W. (2017) · Gut · doi:10.1136/gutjnl-2015-309595 · Cited by 804
Are there two sides to colorectal cancer?
Iacopetta, B. (2002) · International Journal of Cancer · doi:10.1002/ijc.10635 · Cited by 782
Petrelli, F., Tomasello, G., Borgonovo, K., Ghidini, M., Turati, L., Dallera, P., Passalacqua, R., Sgroi, G., & Barni, S. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.4227 · Cited by 729
Bufill, J. A. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-10-779 · Cited by 722
Tejpar, S., Stintzing, S., Ciardiello, F., Tabernero, J., Van Cutsem, E., Beier, F., Esser, R., Lenz, H.-J., & Heinemann, V. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.3797 · Cited by 709
Self-citationMicrobiota organization is a distinct feature of proximal colorectal cancers
Dejea, C. M., Wick, E. C., Hechenbleikner, E. M., White, J. R., Mark Welch, J. L., Rossetti, B. J., Peterson, S. N., Snesrud, E. C., Borisy, G. G., Lazarev, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406199111 · Cited by 700
Engstrom, P. F., Arnoletti, J. P., Benson, A. B., Chen, Y.-J., Choti, M. A., Cooper, H. S., Covey, A., Dilawari, R. A., Early, D. S., Enzinger, P. C., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0056 · Cited by 683
Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features
Missiaglia, E., Jacobs, B., D'Ario, G., Di Narzo, A. F., Soneson, C., Budinska, E., Popovici, V., Vecchione, L., Gerster, S., Yan, P., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu275 · Cited by 646
Self-citationYamauchi, M., Morikawa, T., Kuchiba, A., Imamura, Y., Qian, Z. R., Nishihara, R., Liao, X., Waldron, L., Hoshida, Y., Huttenhower, C., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300865 · Cited by 606
Microbiota disbiosis is associated with colorectal cancer
Gao, Z., Guo, B., Gao, R., Zhu, Q., & Qin, H. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00020 · Cited by 537
Holch, J. W., Ricard, I., Stintzing, S., Modest, D. P., & Heinemann, V. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2016.10.007 · Cited by 534
Self-citationPrimary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer
Loupakis, F., Yang, D., Yau, L., Feng, S., Cremolini, C., Zhang, W., Maus, M. K. H., Antoniotti, C., Langer, C., Scherer, S. J., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju427 · Cited by 472
Self-citationWeiss, J. M., Pfau, P. R., O'Connor, E. S., King, J., LoConte, N., Kennedy, G., & Smith, M. A. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.4414 · Cited by 412
Mouradov, D., Sloggett, C., Jorissen, R. N., Love, C. G., Li, S., Burgess, A. W., Arango, D., Strausberg, R. L., Buchanan, D., Wormald, S., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0013 · Cited by 375
Venook, A. P., Niedzwiecki, D., Innocenti, F., Fruth, B., Greene, C., O'Neil, B. H., Shaw, J. E., Atkins, J. N., Horvath, L. E., Polite, B. N., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.34.15_suppl.3504 · Cited by 336
Self-citationBrulé, S. Y., Jonker, D. J., Karapetis, C. S., O’Callaghan, C. J., Moore, M. J., Wong, R., Tebbutt, N. C., Underhill, C., Yip, D., Zalcberg, J. R., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.03.015 · Cited by 332
Two colons‐two cancers: Paradigm shift and clinical implications
Gervaz, P., Bucher, P., & Morel, P. (2004) · Journal of Surgical Oncology · doi:10.1002/jso.20156 · Cited by 302
Shen, H. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i21.6470 · Cited by 214
Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease?
Price, T. J., Beeke, C., Ullah, S., Padbury, R., Maddern, G., Roder, D., Townsend, A. R., Moore, J., Roy, A., Tomita, Y., et al. (2015) · Cancer · doi:10.1002/cncr.29129 · Cited by 170
Raghav, K., Loree, J. M., Morris, J. S., Overman, M. J., Yu, R., Meric-Bernstam, F., Menter, D., Korphaisarn, K., Kee, B., Muranyi, A., et al. (2019) · JCO Precision Oncology · doi:10.1200/po.18.00226 · Cited by 132
Zhang, Y., Hoffmeister, M., Weck, M. N., Chang-Claude, J. C., & Brenner, H. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr331 · Cited by 122
von Einem, J. C., Heinemann, V., von Weikersthal, L. F., Vehling‐Kaiser, U., Stauch, M. B., Hass, H. G., Decker, T. W., Klein, S., Held, S., Jung, A., et al. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1678-3 · Cited by 116
Self-citationBendardaf, R., Buhmeida, A. S., Hilska, M., Laato, M. K., Syrjänen, S., Syrjänen, K. J., Collan, Y. U., & Pyrhönen, S. O. (2008) · PubMed · Cited by 116
Hemminki, K., Santi, I., Weires, M., Thomsen, H., Sundquist, J., & Bermejo, J. L. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-688 · Cited by 106
Lee, M. S., McGuffey, E. J., Morris, J. S., Manyam, G. C., Baladandayuthapani, V., Wei, W., Morris, V. K., Overman, M. J., Maru, D. M., Jiang, Z.-Q., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.87 · Cited by 99
Kohoutová, D., Šmajs, D., Morávková, P., Cyrany, J., Morávková, M., Forstlova, M., Čihák, M., Rejchrt, S., & Bureš, J. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0733-7 · Cited by 96
Right Sided Colon Cancer as a Distinct Histopathological Subtype with Reduced Prognosis
Nitsche, U., Stögbauer, F., Späth, C., Haller, B., Wilhelm, D., Friess, H., & Bader, F. G. (2016) · Digestive Surgery · doi:10.1159/000443644 · Cited by 96
Region‐specific gastrointestinal Hox code during murine embryonal gut development
Kawazoe, Y., Sekimoto, T., Araki, M., Takagi, K., Araki, K., & Yamamura, K. (2002) · Development Growth & Differentiation · doi:10.1046/j.1440-169x.2002.00623.x · Cited by 90
Sinicrope, F. A., Mahoney, M. R., Yoon, H. H., Smyrk, T. C., Thibodeau, S. N., Goldberg, R. M., Nelson, G. D., Sargent, D. J., & Alberts, S. R. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0527 · Cited by 88
Right- and left-sided colorectal cancers respond differently to cetuximab
Wang, F., Bai, L., Liu, T.-S., Yu, Y.-Y., He, M.-M., Liu, K.-Y., Luo, H., Zhang, D.-S., Jin, Y., Wang, F., et al. (2015) · 癌症:英文版 · doi:10.1186/s40880-015-0022-x · Cited by 77
Raghav, K. P. S., Overman, M. J., Yu, R., Meric‐Bernstam, F., Menter, D. G., Kee, B. K., Murányi, A., Singh, S., Routbort, M. J., Chen, K., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.34.15_suppl.3517 · Cited by 74
Refining Molecular Analysis in the Pathways of Colorectal Carcinogenesis
Rowan, A., Halford, S. E. R., Gaasenbeek, M., et al. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00618-x · Cited by 63
Mutations in the RAS and PI3K pathways are associated with metastatic location in colorectal cancers
Lan, Y., Lin, J., Lin, C., Yang, S., Lin, C., Wang, H., Chen, W., Lin, T., Jiang, J., & Chang, S. (2015) · Journal of Surgical Oncology · doi:10.1002/jso.23895 · Cited by 58
Impact of Primary Tumor Site on Bevacizumab Efficacy in Metastatic Colorectal Cancer
Wong, H., Lee, B., Field, K. M., Lomax, A. J., TACEY, M. A., Shapiro, J. D., McKendrick, J., Zimet, A. S., Yip, D., Nott, L. M., et al. (2016) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2016.02.007 · Cited by 55
Self-citationModest, D. P., Schulz, C. U., von Weikersthal, L. F., Quietzsch, D., von Einem, J. C., Schalhorn, A., Vehling‐Kaiser, U., Laubender, R. P., Giessen, C. A., Stintzing, S., et al. (2013) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000041 · Cited by 48
Self-citationLenz, H., Lee, F.-C., Yau, L., Koh, H. A., Knost, J. A., Mitchell, E. P., Bosanac, I., Mancao, C., & Parikh, A. R. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.34.4_suppl.493 · Cited by 30
Self-citationNasir, A., Kaiser, H. E., Boulware, D. C., Hakam, A., Zhao, H., Yeatman, T. J., Barthel, J. S., & Coppola, D. (2004) · Clinical Colorectal Cancer · doi:10.3816/ccc.2004.n.005 · Cited by 29
Matsusaka, S., Hanna, D. L., Cao, S., Zhang, W., Yang, D., Ning, Y., Sunakawa, Y., Okazaki, S., Berger, M. D., Miyamato, Y., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2422 · Cited by 25
Self-citationBoeckx, N., Toler, A., de Beeck, K. O., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw363.37 · Cited by 22
Lu, H., Lin, J.-K., Chen, W.-S., Jiang, J., Yang, S.-H., Lan, Y., Lin, C., Chang, S., & Teng, H. (2016) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.12469 · Cited by 19
Houts, A. C., Ogale, S. S., Sommer, N., Satram‐Hoang, S., & Walker, M. S. (2017) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-017-0027-6 · Cited by 15
Modest, D. P., Stintzing, S., von Weikersthal, L. F., Decker, T. W., Kiani, A., Vehling‐Kaiser, U., Al‐Batran, S., Heintges, T., Kahl, C., Seipelt, G., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.35.15_suppl.3525 · Cited by 6
Self-citation
Cited by
Testa, U., Pelosi, E., & Castelli, G. (2018) · Medical Sciences · doi:10.3390/medsci6020031 · Cited by 374
Heterogeneity in Colorectal Cancer: A Challenge for Personalized Medicine?
Molinari, C., Marisi, G., Passardi, A., Matteucci, L., De Maio, G., & Ulivi, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123733 · Cited by 262
Lenz, H.-J., Ou, F.-S., Venook, A. P., Hochster, H. S., Niedzwiecki, D., Goldberg, R. M., Mayer, R. J., Bertagnolli, M. M., Blanke, C. D., Zemla, T., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.02258 · Cited by 246
Self-citationAhcene Djaballah, S., Daniel, F., Milani, A., Ricagno, G., & Lonardi, S. (2022) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_351354 · Cited by 95
Fernández Montes, A., Alonso Orduña, V., Asensio Martínez, E., Rodríguez Salas, N., Torres, E., Cacho Lavín, D., Rodríguez Alonso, R. M., Falcó, E., Oliva, J. C., Cirera, L., et al. (2023) · The Oncologist · doi:10.1093/oncolo/oyad117 · Cited by 17
Metadata
- Authors
- Stintzing, S., Tejpar, S., Gibbs, P., Thiebach, L., & Lenz, H.-J.
- Venue
- European Journal of Cancer
- Publisher
- Elsevier BV
- Published
- 2017-10
- Volume
- 84
- Pages
- 69-80
- ISSN
- 0959-8049 (ISSN-L)
- OpenAlex
- W2744203203
- Cited by
- 277
- References
- 49
- FWCI
- 11.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.